Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60 Sep 27, 2016
Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant Sep 26, 2016
Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial Sep 21, 2016
Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial Sep 20, 2016
Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference Sep 19, 2016
Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference Sep 13, 2016
Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference Sep 9, 2016
Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams Sep 7, 2016
